Cephagenix ApS: Financial statements 2022
CVR: 41175486
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Cephagenix ApS (CVR 41175486) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -3,063,396 and a net result of DKK -2,197,967 compared with DKK -1,399,077 the year before. Equity in the 2022 report amounted to DKK 2,662,341. The solvency ratio was 72.9%.
- Gross Profit
- DKK -3,063,396
- Profit/Loss
- DKK -2,197,967
- Equity
- DKK 2,662,341
- Total Assets
- DKK 3,651,692
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -3.1M | -2.2M | 2.7M | 0 |
| 2021 | - | -1.9M | -1.4M | 1.6M | - |
| 2020 | - | -1.3M | -941K | 259K | - |
Official annual report
Keep an eye on Cephagenix ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Cephagenix ApS has published its annual report for 2021. Gross profit came to DKK -1,946,756, and the net result was DKK -1,399,077.
About Cephagenix ApS
Cephagenix ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ismahane Bali. The company is owned by Cephagenix SAS. According to the 2024 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -176,320 and a net result of DKK -105,608 compared with DKK -2,474,554 the year before. Equity in the 2024 report amounted to DKK 82,179.